Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69 | Current Angiogenesis | journal | 0.229 Q3 | 6 | 0 | 50 | 0 | 16 | 43 | 0.10 | 0.00 | 0.00 | |
68 | Current Clinical Pharmacology | journal | 0.733 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
67 | Current Drug Abuse Reviews | journal | 0.752 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
66 | Current Psychiatry Reviews | journal | 0.345 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
65 | Open Biomarkers Journal | journal | 0.108 Q4 | 7 | 0 | 3 | 0 | 1 | 3 | 0.00 | 0.00 | 0.00 | |
64 | Open Medical Devices Journal | journal | 0.123 Q4 | 5 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
63 | Recent Patents on Drug Delivery and Formulation | journal | 0.327 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
62 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.353 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
61 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.720 Q1 | 29 | 25 | 67 | 58 | 121 | 65 | 1.69 | 2.32 | 42.06 | |
60 | Current Signal Transduction Therapy | journal | 0.232 Q3 | 22 | 23 | 78 | 575 | 37 | 72 | 0.09 | 25.00 | 32.20 | |
59 | Open Anesthesia Journal | journal | 7 | 7 | 19 | 176 | 5 | 19 | 0.40 | 25.14 | 32.00 | ||
58 | Open Biomedical Engineering Journal | journal | 0.224 Q3 | 28 | 11 | 88 | 290 | 66 | 87 | 0.61 | 26.36 | 32.69 | |
57 | Open Respiratory Medicine Journal | journal | 0.495 Q3 | 25 | 13 | 49 | 373 | 92 | 46 | 2.03 | 28.69 | 25.40 | |
56 | Open Cardiovascular Medicine Journal | journal | 0.319 Q3 | 32 | 33 | 64 | 1014 | 54 | 64 | 0.83 | 30.73 | 25.50 | |
55 | Drug Metabolism Letters | journal | 0.383 Q3 | 31 | 37 | 61 | 1197 | 66 | 55 | 0.94 | 32.35 | 34.85 | |
54 | Journal of Biology and Today's World (discontinued) | journal | 8 | 37 | 0 | 1234 | 0 | 0 | 0.00 | 33.35 | 43.18 | ||
53 | Current Radiopharmaceuticals | journal | 0.453 Q3 | 32 | 32 | 68 | 1103 | 91 | 64 | 0.95 | 34.47 | 36.57 | |
52 | Current Chemical Biology | journal | 0.267 Q3 | 26 | 17 | 54 | 619 | 63 | 50 | 0.61 | 36.41 | 40.48 | |
51 | Anti-Infective Agents | journal | 0.151 Q4 | 26 | 20 | 58 | 746 | 29 | 52 | 0.49 | 37.30 | 31.08 | |
50 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.616 Q2 | 45 | 10 | 87 | 374 | 151 | 79 | 1.33 | 37.40 | 16.00 | |
49 | Combinatorial Chemistry and High Throughput Screening | journal | 0.301 Q3 | 70 | 97 | 281 | 3741 | 275 | 253 | 0.91 | 38.57 | 39.44 | |
48 | Current Drug Safety | journal | 0.462 Q3 | 41 | 52 | 121 | 2077 | 174 | 113 | 1.13 | 39.94 | 42.71 | |
47 | Current Drug Therapy | journal | 0.165 Q3 | 20 | 14 | 70 | 572 | 30 | 64 | 0.37 | 40.86 | 36.36 | |
46 | Current Nutrition and Food Science | journal | 0.279 Q3 | 32 | 45 | 125 | 1924 | 87 | 114 | 0.42 | 42.76 | 50.31 | |
45 | Open AIDS Journal | journal | 0.895 Q2 | 22 | 21 | 34 | 900 | 58 | 32 | 1.19 | 42.86 | 45.30 | |
44 | Infectious Disorders - Drug Targets | journal | 0.554 Q2 | 61 | 27 | 99 | 1165 | 146 | 89 | 1.41 | 43.15 | 48.35 | |
43 | Current Neurovascular Research | journal | 0.820 | 60 | 45 | 136 | 1964 | 321 | 123 | 2.35 | 43.64 | 38.57 | |
42 | Recent Patents on CNS Drug Discovery | journal | 0.513 Q2 | 36 | 18 | 45 | 786 | 76 | 38 | 1.48 | 43.67 | 52.83 | |
41 | Current Computer-Aided Drug Design | journal | 0.277 Q3 | 32 | 34 | 134 | 1503 | 145 | 119 | 0.79 | 44.21 | 32.18 | |
40 | Clinical Practice and Epidemiology in Mental Health | journal | 0.834 Q2 | 58 | 20 | 78 | 887 | 171 | 77 | 1.84 | 44.35 | 40.00 | |
39 | Current Medical Imaging | journal | 0.304 Q3 | 37 | 48 | 101 | 2222 | 58 | 95 | 0.40 | 46.29 | 37.97 | |
38 | Current Nanoscience | journal | 0.272 Q3 | 52 | 105 | 368 | 4903 | 408 | 353 | 1.06 | 46.70 | 36.80 | |
37 | Recent patents on food, nutrition & agriculture | journal | 0.270 Q3 | 33 | 26 | 59 | 1266 | 64 | 54 | 0.81 | 48.69 | 56.10 | |
36 | Current Pediatric Reviews | journal | 0.279 Q3 | 33 | 26 | 127 | 1290 | 89 | 113 | 1.00 | 49.62 | 43.14 | |
35 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.359 Q3 | 43 | 26 | 90 | 1309 | 80 | 76 | 0.70 | 50.35 | 45.87 | |
34 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.153 Q4 | 17 | 19 | 70 | 965 | 21 | 62 | 0.23 | 50.79 | 35.82 | |
33 | Current Cancer Therapy Reviews | journal | 0.183 Q4 | 17 | 21 | 86 | 1067 | 27 | 78 | 0.25 | 50.81 | 40.48 | |
32 | Open Hypertension Journal | journal | 0.117 Q4 | 6 | 1 | 37 | 51 | 11 | 25 | 0.17 | 51.00 | 0.00 | |
31 | Reviews on Recent Clinical Trials | journal | 0.484 Q2 | 35 | 42 | 111 | 2198 | 148 | 97 | 1.46 | 52.33 | 42.95 | |
30 | Open Neuroimaging Journal | journal | 9 | 13 | 0 | 682 | 0 | 0 | 0.00 | 52.46 | 27.12 | ||
29 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.648 Q3 | 63 | 39 | 130 | 2067 | 264 | 119 | 2.21 | 53.00 | 45.00 | |
28 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.267 Q3 | 27 | 25 | 76 | 1341 | 74 | 67 | 0.96 | 53.64 | 39.56 | |
27 | Current Hypertension Reviews | journal | 0.619 Q2 | 27 | 34 | 93 | 1858 | 134 | 83 | 1.38 | 54.65 | 42.11 | |
26 | Current Pharmacogenomics and Personalized Medicine | journal | 0.118 Q4 | 20 | 15 | 79 | 872 | 24 | 73 | 0.24 | 58.13 | 50.00 | |
25 | Current Metabolomics | journal | 4 | 6 | 3 | 353 | 1 | 3 | 0.33 | 58.83 | 30.00 | ||
24 | Current Vascular Pharmacology | journal | 0.890 Q2 | 69 | 87 | 299 | 5574 | 629 | 252 | 2.15 | 64.07 | 38.16 | |
23 | Current Respiratory Medicine Reviews | journal | 0.270 Q3 | 15 | 40 | 142 | 2596 | 60 | 116 | 0.18 | 64.90 | 25.00 | |
22 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 70 | 1540 | 91 | 66 | 1.38 | 70.00 | 36.67 | ||
21 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 35 | 134 | 2490 | 247 | 122 | 1.59 | 71.14 | 31.97 | ||
20 | Current Cardiology Reviews | journal | 1.071 Q1 | 58 | 40 | 134 | 2921 | 316 | 121 | 1.60 | 73.03 | 27.88 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®